
Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy,
Description
Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)
The Asia Pacific circulating tumor cell (CTC) diagnostics market is expected to reach US$ 689.3 million by 2028 from US$ 347.6 million in 2021. The market is estimated to grow at a CAGR of 10.3% from 2021 to 2028.
The rising demand for liquid biopsies for cancer detection is expected to boost the demand for circulating tumor cell diagnostics. Leading market players focus on enlarging their reach across emerging markets by expanding their distribution networks and augmenting manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities for crucial circulating tumor cell (CTC) diagnostics market players in the coming years. This can be attributed to the large patient population, high cancer prevalence (including types such as skin, breasts, lungs, pancreas, and other organs and glands), increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. As the markets mature, most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading their healthcare infrastructure with the latest technologies. This factor, in turn, supports the progress in cancer diagnostics, thereby creating new opportunities for the Asia Pacific circulating tumor cell (CTC) diagnostics market players.
Prohibitive measures have been taken to contain the spread of the COVID-19 pandemic in APAC countries. The pandemic has largely affected the economies of India, China, Japan, and South Korea, among others. The onset of the pandemic and exponential rise in patients with the need of hospitalization led to delays and temporary suspension of cancer screening, diagnosis, and treatment services. Moreover, government regulations, nationwide lockdowns, and spiking infection rates had a significant financial impact on healthcare facilities. Several hospitals and clinics have seen a decrease in patient visits as a result of COVID-19. The scarcity of medical care and supplies for conditions other than COVID-19 had a detrimental impact on the circulating tumor cell diagnostics market proliferation. At the same time, limited healthcare staff availability hampered the circulating tumor cell diagnostics market in Asia Pacific. In addition, the socio-economy was badly hit, with growing inflation, declining GDP, and rising unemployment in the region. The pandemic has affected three main aspects of the global economy: manufacturing, supply chain, and business and financial markets.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The Asia Pacific circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.
Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
By Technology
CTC detection and Enrichment Method CTC Direct Detection Methods CTC Analysis By Application
Clinical/Liquid Biopsy Risk Assessment Screening and Monitoring Research Cancer Stem Cell and Tumorigenesis Research Drug/Therapy Development
By End-User
Hospitals and Clinics Research and Academic Institutes Diagnostic Centers
By Country
China Japan India South Korea Australia Rest of Asia Pacific
Companies Mentioned
Thermo Fisher Scientific Inc. Stemcell Technologies Inc. Qiagen Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation) Screencell Fluxion Biosciences
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific circulating tumor cell (CTC) diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The Asia Pacific circulating tumor cell (CTC) diagnostics market is expected to reach US$ 689.3 million by 2028 from US$ 347.6 million in 2021. The market is estimated to grow at a CAGR of 10.3% from 2021 to 2028.
The rising demand for liquid biopsies for cancer detection is expected to boost the demand for circulating tumor cell diagnostics. Leading market players focus on enlarging their reach across emerging markets by expanding their distribution networks and augmenting manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities for crucial circulating tumor cell (CTC) diagnostics market players in the coming years. This can be attributed to the large patient population, high cancer prevalence (including types such as skin, breasts, lungs, pancreas, and other organs and glands), increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. As the markets mature, most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading their healthcare infrastructure with the latest technologies. This factor, in turn, supports the progress in cancer diagnostics, thereby creating new opportunities for the Asia Pacific circulating tumor cell (CTC) diagnostics market players.
Prohibitive measures have been taken to contain the spread of the COVID-19 pandemic in APAC countries. The pandemic has largely affected the economies of India, China, Japan, and South Korea, among others. The onset of the pandemic and exponential rise in patients with the need of hospitalization led to delays and temporary suspension of cancer screening, diagnosis, and treatment services. Moreover, government regulations, nationwide lockdowns, and spiking infection rates had a significant financial impact on healthcare facilities. Several hospitals and clinics have seen a decrease in patient visits as a result of COVID-19. The scarcity of medical care and supplies for conditions other than COVID-19 had a detrimental impact on the circulating tumor cell diagnostics market proliferation. At the same time, limited healthcare staff availability hampered the circulating tumor cell diagnostics market in Asia Pacific. In addition, the socio-economy was badly hit, with growing inflation, declining GDP, and rising unemployment in the region. The pandemic has affected three main aspects of the global economy: manufacturing, supply chain, and business and financial markets.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The Asia Pacific circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.
Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
By Technology
CTC detection and Enrichment Method CTC Direct Detection Methods CTC Analysis By Application
Clinical/Liquid Biopsy Risk Assessment Screening and Monitoring Research Cancer Stem Cell and Tumorigenesis Research Drug/Therapy Development
By End-User
Hospitals and Clinics Research and Academic Institutes Diagnostic Centers
By Country
China Japan India South Korea Australia Rest of Asia Pacific
Companies Mentioned
Thermo Fisher Scientific Inc. Stemcell Technologies Inc. Qiagen Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation) Screencell Fluxion Biosciences
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific circulating tumor cell (CTC) diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
129 Pages
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market - By Technology
- 1.3.2 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market - By Application
- 1.3.3 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market - By End-User
- 1.3.4 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market - By Geography
- 2. Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. Circulating Tumor Cell (CTC) Diagnostics Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
- 4.3 Experts Opinion
- 5. Circulating Tumor Cell (CTC) Diagnostics Market- Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Cancer
- 5.1.2 Rising Demand for Minimally Invasive Diagnostic Procedures
- 5.2 Market Restraints
- 5.2.1 Dearth of Skilled Professionals Performing Diagnostic Procedures
- 5.3 Market Opportunities
- 5.3.1 Untapped Potential of Emerging Economies
- 5.4 Future Trends
- 5.4.1 Technological Advancements in Isolation of Circulating Tumor Cell
- 5.5 Impact Analysis
- 6. Circulating Tumor Cell (CTC) Diagnostics Market- Asia Pacific Analysis
- 6.1 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis
- 7. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 - Technology
- 7.1 Overview
- 7.2 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)
- 7.3 CTC detection and Enrichment Method
- 7.3.1 Overview
- 7.3.2 CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 7.4 CTC Direct Detection Method
- 7.4.1 Overview
- 7.4.2 CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 7.5 CTC Analysis
- 7.5.1 Overview
- 7.5.2 CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 - Application
- 8.1 Overview
- 8.2 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)
- 8.3 Clinical/Liquid Biopsy
- 8.3.1 Overview
- 8.3.2 Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.3.3 Risk Assessment
- 8.3.3.1 Overview
- 8.3.3.2 Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.3.4 Screening and Monitoring
- 8.3.4.1 Overview
- 8.3.4.2 Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.4 Research
- 8.4.1 Overview
- 8.4.2 Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.2.1 Cancer Stem Cell & Tumorigenesis Research
- 8.4.2.1.1 Overview
- 8.4.2.1.2 Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.2.2 Drug/Therapy Development
- 8.4.2.2.1 Overview
- 8.4.2.2.2 Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 9. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 - End user
- 9.1 Overview
- 9.2 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)
- 9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 9.4 Research and Academic Institutes
- 9.4.1 Overview
- 9.4.2 Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 9.5 Diagnostic Centers
- 9.5.1 Overview
- 9.5.2 Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 10. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market - Geographic Analysis
- 10.1 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market
- 10.1.1 Overview
- 10.1.2 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.3 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.4 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.4.1 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.4.2 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.5 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 10.1.6 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
- 10.1.6.1 China: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.1.1 China: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.1.2 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.6.1.3 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.6.1.3.1 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.6.1.3.2 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.6.1.4 China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 10.1.6.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.2.1 Japan: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.2.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.6.2.3 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.6.2.3.1 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.6.2.3.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.6.2.4 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 10.1.6.3 India: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.3.1 India: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.3.2 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.6.3.3 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.6.3.3.1 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.6.3.3.2 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.6.3.4 India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 10.1.6.4 Australia: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.4.1 Australia: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.4.2 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.6.4.3 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.6.4.3.1 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.6.4.3.2 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.6.4.4 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 10.1.6.5 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.5.1 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.5.2 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.6.5.3 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.6.5.3.1 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.6.5.3.2 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.6.5.4 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 10.1.6.6 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.6.1 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.6.6.2 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019-2028 (US$ Million)
- 10.1.6.6.3 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019-2028 (US$ Million)
- 10.1.6.6.3.1 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019-2028 (US$ Million)
- 10.1.6.6.3.2 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019-2028 (US$ Million)
- 10.1.6.6.4 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019-2028 (US$ Million)
- 11. Impact of COVID-19 Pandemic on Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market
- 11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
- 12. Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)
- 12.3 Organic Developments
- 12.3.1 Overview
- 12.4 Inorganic Developments
- 12.4.1 Overview
- 13. Company Profiles
- 13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 STEMCELL Technologies Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 QIAGEN
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 SCREENCELL
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 FLUXION BIOSCIENCES
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 14. Appendix
- 14.1 About The Insight Partners
- 14.2 Glossary of Terms
- List of Tables
- Table 1. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
- Table 2. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
- Table 3. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 4. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User - Revenue and Forecast to 2028 (US$ Million)
- Table 6. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
- Table 7. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
- Table 8. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 9. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research - Revenue and Forecast to 2028 (US$ Million)
- Table 10. China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User - Revenue and Forecast to 2028 (US$ Million)
- Table 11. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
- Table 12. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
- Table 13. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 14. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research - Revenue and Forecast to 2028 (US$ Million)
- Table 15. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User - Revenue and Forecast to 2028 (US$ Million)
- Table 16. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
- Table 17. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application- Revenue and Forecast to 2028 (US$ Million)
- Table 18. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/ Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 19. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research- Revenue and Forecast to 2028 (US$ Million)
- Table 20. India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User- Revenue and Forecast to 2028 (US$ Million)
- Table 21. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
- Table 22. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
- Table 23. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 24. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research - Revenue and Forecast to 2028 (US$ Million)
- Table 25. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User - Revenue and Forecast to 2028 (US$ Million)
- Table 26. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
- Table 27. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
- Table 28. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 29. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research - Revenue and Forecast to 2028 (US$ Million)
- Table 30. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User - Revenue and Forecast to 2028 (US$ Million)
- Table 31. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
- Table 32. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
- Table 33. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy - Revenue and Forecast to 2028 (US$ Million)
- Table 34. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research - Revenue and Forecast to 2028 (US$ Million)
- Table 35. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User - Revenue and Forecast to 2028 (US$ Million)
- Table 36. Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market
- Table 37. Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market
- Table 38. Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market
- List of Figures
- Figure 1. Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
- Figure 2. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Overview
- Figure 3. CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market
- Figure 4. China is Expected to Show Remarkable Growth During the Forecast Period
- Figure 5. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape
- Figure 6. Asia Pacific: PEST Analysis
- Figure 7. Experts Opinion
- Figure 8. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
- Figure 9. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)
- Figure 10. CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 11. CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 12. CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)
- Figure 14. Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)
- Figure 21. Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
- Figure 25. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
- Figure 27. China: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 28. Japan: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 29. India: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 30. Australia: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 31. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 33. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Figure 34. Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.